Medical devices
10 Becton Dickinson finance leaders
These ten current and former Becton Dickinson (BD) finance leaders, including Becton Dickinson's current CFO and a former CFO, have held CFO, controller, treasurer and finance vice president roles at BD. A reader can learn how BD organizes finance across its segments, business units and regions, from FP&A to controllership and treasury.
Professionals to explore
01—10Christian Magnet
LinkedInExperience: Vice President Finance · BD
Vice President Finance at BD, with two entries dated from October 2014 and May 2015 to the present; the headline describes the role as Vice President Finance EMEA. Magnet also held BD roles as Regional Controller EMA (2012–2014), European Financial Controller (2011–2014) and Director of Financial Operations Europe (2010–2011). The highlight mentions more than 25 years in finance, including external audit at PwC and a regional CFO role with Chevron.
Christopher DelOrefice
LinkedInExperience: Executive Vice President and Chief Financial Officer · BD
Former Executive Vice President and Chief Financial Officer of BD (2021–2025), based in Franklin Lakes, New Jersey according to the highlight, and Chief Financial Officer at Ulta Beauty since December 2025. DelOrefice was also Vice President, Investor Relations at Johnson & Johnson (2018–2021) and Chief Financial Officer, North America Hospital Medical Devices at Johnson & Johnson MedTech (2017–2018).
Devan Durante
LinkedInExperience: Vice President Finance - BD Medical Segment - FP&A · BD
Vice President Finance - BD Medical Segment - FP&A at BD since January 2025, based in Providence, Rhode Island according to the highlight. Durante also held BD roles as Director of Global FP&A - BDI Surgery (2023–2025), Director, Operations Finance - Life Sciences, Integrated Diagnostic Systems (2020–2023) and Sr. Finance Manager Controller (2018–2020).
John Gallagher
LinkedInExperience: Senior Vice President Finance, Controller & Treasurer · BD
Former Senior Vice President Finance, Controller & Treasurer at BD (2014–2021); the highlight lists the role's scope as controller, chief accounting officer, treasurer and FP&A. Gallagher was also Vice President, Financial Planning & Analysis and Treasurer at BD (2013–2014), Chief Financial Officer at Cue Health (2021–2023) and Certara (2023–2026), and is EVP, Chief Financial Officer at CONMED Corporation since 2026.
Mark Abbasi
LinkedInExperience: Business Unit CFO - Advanced Patient Monitoring (formerly Edwards Critical Care) · BD
Business Unit CFO - Advanced Patient Monitoring (formerly Edwards Critical Care) at BD since September 2024. Abbasi was also Senior Vice President Finance, Business Unit CFO - Critical Care at Edwards Lifesciences (2021–2024) and Vice President Finance, Transcatheter Aortic Valve Replacement (TAVR) at Edwards Lifesciences (2020–2021).
Michele Healy
LinkedInExperience: VP Finance, Connected Care · BD
VP Finance, Connected Care at BD since March 2026, and VP Finance, Integrated Diagnostic Solutions at BD from 2018 to 2023. Healy was Chief Financial Officer at Selux Diagnostics, Inc (2023–2026) and also held BD roles as Finance Director, BP&A Transformation (2017–2018) and Worldwide Assistant Controller, Diabetes Care (2011–2017).
Thomas Spoerel
LinkedInExperience: SVP Finance, Controller & Chief Accounting Officer · BD
Former SVP Finance, Controller & Chief Accounting Officer at BD (2019–2024) and SVP Finance, CFO Regions at BD (2024–2026). The highlight says the CFO Regions role included oversight of US and International businesses, providing finance leadership support on strategy development and performance management. Spoerel was also VP Finance - Deputy Controller at BD (2015–2019) and is Chief Accounting Officer at Shift4 since 2026.
Thomas Valente
LinkedInExperience: VP Finance, Americas · BD
Former VP Finance, Americas at BD (2017–2022) and Vice President Finance - BD USA (2014–2022); the highlight describes Valente as retired from BD. Valente also held BD roles as Worldwide Controller -PAS, BD Diagnostics (2007–2013) and Assistant Corporate Controller (2004–2006).
Ulrich Stefer
LinkedInExperience: Vice President Finance Greater Asia · BD
Vice President Finance Greater Asia at BD since June 2024. Stefer was also Chief Financial Officer (SVP) - Greater China, Bayer Group of Companies at Bayer (China) Ltd. (2019–2024), Chief Financial Officer (VP) - South Asia, Bayer Group of Companies at Bayer (2016–2019) and VP Head of International Taxes at Bayer (2010–2013).
Vitor Roque
LinkedInExperience: Executive Vice President, Chief Financial Officer · BD
Executive Vice President, Chief Financial Officer at BD since May 2026, and Interim Chief Financial Officer at BD from December 2025 to May 2026. Roque also held BD roles as Senior Vice President Finance, Business Units & Corp. FP&A (2024–2026), Vice President & Chief Financial Officer - BD Medical Segment (2021–2024) and Vice President Finance, Medication Management Solutions (2019–2021).
Choose the right perspective
Match the person's scope to your question: corporate finance leaders suit questions about reporting, controls, treasury and planning, while segment, business-unit and regional finance leaders suit questions about product-line economics or a specific market. Check whether the BD role is current or past before asking about recent practices.
Questions to take into the conversation
- 01How should finance partner with segment and business-unit leaders on planning and performance targets in a medical device company?
- 02What does a strong controllership and close process look like across many countries and manufacturing sites?
- 03How should finance lead the integration of an acquired medical device business?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal